X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1484) 1484
Publication (24) 24
Newspaper Article (12) 12
Patent (12) 12
Book Chapter (11) 11
Book / eBook (5) 5
Web Resource (3) 3
Conference Proceeding (1) 1
Magazine Article (1) 1
Newsletter (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (635) 635
male (476) 476
female (456) 456
middle aged (403) 403
risk factors (367) 367
cardiac & cardiovascular systems (311) 311
atherosclerosis (255) 255
aged (250) 250
cardiovascular (235) 235
cholesterol (229) 229
cardiovascular disease (192) 192
abridged index medicus (174) 174
lipids (146) 146
peripheral vascular disease (142) 142
coronary-heart-disease (130) 130
cardiovascular diseases (128) 128
risk (128) 128
statins (126) 126
adult (123) 123
cholesterol, ldl - blood (123) 123
mortality (123) 123
diabetes (116) 116
biomarkers - blood (111) 111
prevention (107) 107
prospective studies (106) 106
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (101) 101
inflammation (101) 101
animals (99) 99
research (98) 98
treatment outcome (97) 97
coronary heart disease (96) 96
risk assessment (96) 96
c-reactive protein (91) 91
epidemiology (90) 90
internal medicine (90) 90
association (89) 89
united states - epidemiology (87) 87
cardiovascular-disease (84) 84
follow-up studies (83) 83
analysis (80) 80
cardiology (79) 79
triglycerides (79) 79
incidence (78) 78
double-blind method (77) 77
heart failure (77) 77
atherosclerosis risk (75) 75
cholesterol, hdl - blood (74) 74
disease (74) 74
lipoproteins (74) 74
drug therapy (73) 73
obesity (73) 73
time factors (73) 73
health aspects (72) 72
care and treatment (71) 71
cohort studies (70) 70
low density lipoproteins (70) 70
mice (69) 69
hypercholesterolemia (66) 66
triglycerides - blood (66) 66
anticholesteremic agents - therapeutic use (61) 61
endocrinology & metabolism (61) 61
hypertension (61) 61
biomarkers (60) 60
myocardial-infarction (59) 59
stroke (59) 59
low density lipoprotein (57) 57
heart attacks (56) 56
prognosis (56) 56
events (54) 54
medical research (54) 54
studies (54) 54
atherosclerosis - blood (53) 53
lipids - blood (52) 52
medicine, general & internal (52) 52
united states (52) 52
atorvastatin (50) 50
genetics (50) 50
pharmacology & pharmacy (50) 50
drug therapy, combination (49) 49
hypercholesterolemia - drug therapy (49) 49
diabetes mellitus (48) 48
health risk assessment (47) 47
medical colleges (47) 47
density-lipoprotein cholesterol (46) 46
blood pressure (45) 45
diagnosis (45) 45
hypolipidemic agents - therapeutic use (45) 45
population (45) 45
simvastatin (45) 45
clinical trials (44) 44
coronary artery disease (44) 44
metabolic syndrome (44) 44
troponin t - blood (44) 44
ezetimibe (43) 43
heart diseases (43) 43
proportional hazards models (43) 43
usage (43) 43
arteriosclerosis (42) 42
genetic aspects (42) 42
genotype (42) 42
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Stacks (1) 1
Mt Sinai Hospital - Online (1) 1
Robarts - Storage (1) 1
St. Michael's Hospital - Online (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1550) 1550
French (4) 4
Chinese (3) 3
Portuguese (2) 2
Spanish (2) 2
German (1) 1
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 367, Issue 22, pp. 2089 - 2099
Dalcetrapib, an inhibitor of cholesteryl ester transfer protein, raises HDL cholesterol levels. In this clinical trial involving patients with an acute... 
TRIAL | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CARDIOVASCULAR EVENTS | STATIN THERAPY | SAFETY | HIGH-RISK | CHOLESTEROL EFFLUX | PREVENTION | HDL CHOLESTEROL | HIGH-DENSITY-LIPOPROTEIN | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Biomarkers - blood | Apolipoproteins - blood | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Sulfhydryl Compounds - adverse effects | Anticholesteremic Agents - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - mortality | Cholesterol, HDL - blood | Cholesterol, LDL - blood | Female | Aged | Blood Pressure - drug effects | Sulfhydryl Compounds - therapeutic use | C-Reactive Protein - analysis | Measurement | Cholesterol, HDL | Patient outcomes | Dosage and administration | Research | Acute coronary syndrome | Drug therapy | Health aspects | Cardiovascular agents | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | C-reactive protein | Heart attacks | Mortality | Cardiovascular disease | Angina | Coronary artery disease | Cholesterol | Cholesteryl ester transfer protein | Studies | Ischemia | Diet | Biomarkers | Blood pressure | Acute coronary syndromes | Cardiovascular diseases | Heart diseases | Lipoproteins (high density)
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2015, Volume 115, Issue 9, pp. 1212 - 1221
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9802, pp. 1547 - 1559
Summary Background Dalcetrapib modulates cholesteryl ester transfer protein (CETP) activity to raise high-density lipoprotein cholesterol (HDL-C). After the... 
Internal Medicine | RAPID EXTENDED COVERAGE | MEDICINE, GENERAL & INTERNAL | POSITRON-EMISSION-TOMOGRAPHY | ESTER TRANSFER PROTEIN | CARDIOVASCULAR EVENTS | STATIN THERAPY | CHOLESTEROL LEVELS | HIGH-RESOLUTION | CORONARY-HEART-DISEASE | BLOOD-PRESSURE | HIGH-DENSITY-LIPOPROTEIN | Confidence Intervals | Sulfhydryl Compounds - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Magnetic Resonance Imaging - methods | Male | Reference Values | Hypercholesterolemia - drug therapy | Diagnostic Imaging - methods | Dose-Response Relationship, Drug | Young Adult | Coronary Stenosis - prevention & control | Drug-Related Side Effects and Adverse Reactions | Adult | Female | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Coronary Artery Disease - prevention & control | Treatment Outcome | Positron-Emission Tomography - methods | Coronary Artery Disease - diagnosis | Anticholesteremic Agents - administration & dosage | Adolescent | Hypercholesterolemia - diagnosis | Aged | Coronary Stenosis - diagnosis | Research | Diagnosis | Drug therapy | Health aspects | Anticholesteremic agents | Atherosclerosis | Medicine | Medical research | Lipoproteins | Biomedical research | Mortality | Cardiovascular disease | Blood pressure | Clinical medicine | Cholesterol | Proteins | blood pressure | Side effects | enlargement | Esters | cholesterol | clinical trials | Cardiovascular diseases
Journal Article
2009, 1st ed., ISBN 1416054693, xix, 584
Dr. Ballantyne-one of the foremost lipid experts in the world and recruited by Dr. Braunwalds Heart Disease editorial team-together with a stellar cast of... 
Heart | Lipoproteins | Cardiovascular Diseases | Dyslipidemias | complications | Lipids | Lipid Metabolism | metabolism | Diseases
Book
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 380, Issue 1, pp. 11 - 22
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 67, Issue 18, pp. 2118 - 2130
Journal Article